# Influenza Vaccine in Pregnant Women

> **NCT00905125** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 102 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone®
- **BIOLOGICAL:** Fluarix®

## Key facts

- **NCT ID:** NCT00905125
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905125, "Influenza Vaccine in Pregnant Women". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00905125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*